Nytt steg närmare marknaden för Sobis giktläkemedel

Läkemedelsutvecklaren Sobi har inlett en stegvis ansökan om marknadsgodkännande i USA för bolagets nya giktläkemedel Sel-212.

Cytel Sweden

Zelmic

A+ Science AB

Meribel Pharma Solna

KI-studie: Nässköljning kunde ge information om KOL

Förekomsten av ett visst protein i näsan kunde användas som underlag för bedömning av KOL, i en ny studie från forskare vid Karolinska institutet.

Metabolon

Webinar: Support Trial Patients Transitioning to the Commercial Space

Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.

RegFile AB

Mastering Urine Microscopy

On-demand Webinar: Microscopy in urinalysis.

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Sahlgrenska Science Park

LINK Medical Research

Merck Life Science A/S

Kompauto Nordic AB

Medicon Village Science Park

ZEISS Insights: Measurement of bone plates and screws

Get free access to technical paper.

In search of Marcel Proust's lost health

A great writer, but also a weak person and a hypochondriac. That has been the usual image of Marcel Proust. But the pediatrician and literary scholar Carl Lindg...

Claims of life science companies fleeing abroad is a myth according to survey

The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

Are you curious about volume imaging for very large samples?

Exciting ZEISS Webinar!

AstraZeneca moves to brewery quarters in central Copenhagen

AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.

AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.